These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

619 related articles for article (PubMed ID: 31998660)

  • 1. Distinct Immune Responses Elicited From Cervicovaginal Epithelial Cells by Lactic Acid and Short Chain Fatty Acids Associated With Optimal and Non-optimal Vaginal Microbiota.
    Delgado-Diaz DJ; Tyssen D; Hayward JA; Gugasyan R; Hearps AC; Tachedjian G
    Front Cell Infect Microbiol; 2019; 9():446. PubMed ID: 31998660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaginal lactic acid elicits an anti-inflammatory response from human cervicovaginal epithelial cells and inhibits production of pro-inflammatory mediators associated with HIV acquisition.
    Hearps AC; Tyssen D; Srbinovski D; Bayigga L; Diaz DJD; Aldunate M; Cone RA; Gugasyan R; Anderson DJ; Tachedjian G
    Mucosal Immunol; 2017 Nov; 10(6):1480-1490. PubMed ID: 28401934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory and antimicrobial properties differ between vaginal Lactobacillus isolates from South African women with non-optimal versus optimal microbiota.
    Manhanzva MT; Abrahams AG; Gamieldien H; Froissart R; Jaspan H; Jaumdally SZ; Barnabas SL; Dabee S; Bekker LG; Gray G; Passmore JS; Masson L
    Sci Rep; 2020 Apr; 10(1):6196. PubMed ID: 32277092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial and immune modulatory effects of lactic acid and short chain fatty acids produced by vaginal microbiota associated with eubiosis and bacterial vaginosis.
    Aldunate M; Srbinovski D; Hearps AC; Latham CF; Ramsland PA; Gugasyan R; Cone RA; Tachedjian G
    Front Physiol; 2015; 6():164. PubMed ID: 26082720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactic acid enhances vaginal epithelial barrier integrity and ameliorates inflammatory effects of dysbiotic short chain fatty acids and HIV-1.
    Schwecht I; Nazli A; Gill B; Kaushic C
    Sci Rep; 2023 Nov; 13(1):20065. PubMed ID: 37973920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactic acid from vaginal microbiota enhances cervicovaginal epithelial barrier integrity by promoting tight junction protein expression.
    Delgado-Diaz DJ; Jesaveluk B; Hayward JA; Tyssen D; Alisoltani A; Potgieter M; Bell L; Ross E; Iranzadeh A; Allali I; Dabee S; Barnabas S; Gamieldien H; Blackburn JM; Mulder N; Smith SB; Edwards VL; Burgener AD; Bekker LG; Ravel J; Passmore JS; Masson L; Hearps AC; Tachedjian G
    Microbiome; 2022 Aug; 10(1):141. PubMed ID: 36045402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of lactic acid production by probiotic Lactobacillus species in vaginal health.
    Tachedjian G; Aldunate M; Bradshaw CS; Cone RA
    Res Microbiol; 2017; 168(9-10):782-792. PubMed ID: 28435139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaginal microbiome.
    Buchta V
    Ceska Gynekol; 2018; 83(5):371-379. PubMed ID: 30848142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal Changes in Vaginal Microbiota and Genital Tract Cytokines Among South African Women Treated for Bacterial Vaginosis.
    Mtshali A; San JE; Osman F; Garrett N; Balle C; Giandhari J; Onywera H; Mngomezulu K; Mzobe G; de Oliveira T; Rompalo A; Mindel A; Abdool Karim SS; Ravel J; Passmore JS; Abdool Karim Q; Jaspan HB; Liebenberg LJP; Ngcapu S
    Front Immunol; 2021; 12():730986. PubMed ID: 34594336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-Sectional Analysis of Selected Genital Tract Immunological Markers and Molecular Vaginal Microbiota in Sub-Saharan African Women, with Relevance to HIV Risk and Prevention.
    Kyongo JK; Crucitti T; Menten J; Hardy L; Cools P; Michiels J; Delany-Moretlwe S; Mwaura M; Ndayisaba G; Joseph S; Fichorova R; van de Wijgert J; Vanham G; Ariën KK; Jespers V
    Clin Vaccine Immunol; 2015 May; 22(5):526-38. PubMed ID: 25761460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-HIV-1 Activity of Lactic Acid in Human Cervicovaginal Fluid.
    Tyssen D; Wang YY; Hayward JA; Agius PA; DeLong K; Aldunate M; Ravel J; Moench TR; Cone RA; Tachedjian G
    mSphere; 2018 Jul; 3(4):. PubMed ID: 29976641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining characteristics of genital health in South African adolescent girls and young women at high risk for HIV infection.
    Dabee S; Barnabas SL; Lennard KS; Jaumdally SZ; Gamieldien H; Balle C; Happel AU; Murugan BD; Williamson AL; Mkhize N; Dietrich J; Lewis DA; Chiodi F; Hope TJ; Shattock R; Gray G; Bekker LG; Jaspan HB; Passmore JS
    PLoS One; 2019; 14(4):e0213975. PubMed ID: 30947260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Lactobacillus crispatus isolates from Lactobacillus-dominated vaginal microbiomes with isolates from microbiomes containing bacterial vaginosis-associated bacteria.
    Abdelmaksoud AA; Koparde VN; Sheth NU; Serrano MG; Glascock AL; Fettweis JM; Strauss JF; Buck GA; Jefferson KK
    Microbiology (Reading); 2016 Mar; 162(3):466-475. PubMed ID: 26747455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Standard Bacterial Vaginosis Treatment on the Genital Microbiota, Immune Milieu, and Ex Vivo Human Immunodeficiency Virus Susceptibility.
    Joag V; Obila O; Gajer P; Scott MC; Dizzell S; Humphrys M; Shahabi K; Huibner S; Shannon B; Tharao W; Mureithi M; Oyugi J; Kimani J; Kaushic C; Ravel J; Anzala O; Kaul R
    Clin Infect Dis; 2019 May; 68(10):1675-1683. PubMed ID: 30407498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial vaginosis and the cervicovaginal immune response.
    Mitchell C; Marrazzo J
    Am J Reprod Immunol; 2014 Jun; 71(6):555-63. PubMed ID: 24832618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lactic acid-containing products for bacterial vaginosis and their impact on the vaginal microbiota: A systematic review.
    Plummer EL; Bradshaw CS; Doyle M; Fairley CK; Murray GL; Bateson D; Masson L; Slifirski J; Tachedjian G; Vodstrcil LA
    PLoS One; 2021; 16(2):e0246953. PubMed ID: 33571286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of Over-The-Counter Lactic Acid Containing Vaginal Gels on the Integrity and Inflammatory State of the Vaginal Epithelium
    Tyssen D; Hearps AC; Guntur K; Masson L; Cook S; Moulton SE; Ravel J; Bradshaw CS; Ayehunie S; Tachedjian G
    Front Reprod Health; 2022; 4():915948. PubMed ID: 36303665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteria in the vaginal microbiome alter the innate immune response and barrier properties of the human vaginal epithelia in a species-specific manner.
    Doerflinger SY; Throop AL; Herbst-Kralovetz MM
    J Infect Dis; 2014 Jun; 209(12):1989-99. PubMed ID: 24403560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaginal fungi are associated with treatment-induced shifts in the vaginal microbiota and with a distinct genital immune profile.
    Armstrong E; Hemmerling A; Miller S; Huibner S; Kulikova M; Liu R; Crawford E; Castañeda GR; Coburn B; Cohen CR; Kaul R
    Microbiol Spectr; 2024 Aug; 12(8):e0350123. PubMed ID: 38912808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cervicovaginal mucus barrier to HIV-1 is diminished in bacterial vaginosis.
    Hoang T; Toler E; DeLong K; Mafunda NA; Bloom SM; Zierden HC; Moench TR; Coleman JS; Hanes J; Kwon DS; Lai SK; Cone RA; Ensign LM
    PLoS Pathog; 2020 Jan; 16(1):e1008236. PubMed ID: 31971984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.